Following the news from China
Provided by AGP
China, US Target Trafficking of New Psychoactive Substances
(MENAFN) China and the United States have jointly dismantled a cross-border network trafficking new psychoactive substances, China's Ministry of Public Security announced Thursday, in a rare display of bilateral law enforcement cooperation amid broader geopolitical tensions between the two powers.
The operation traces back to 2024, when the ministry's narcotics control bureau and the US Drug Enforcement Administration, operating under the Department of Justice, launched a coordinated investigation into the case, a state-run news agency reported.
Acting on intelligence supplied by US authorities, Chinese police moved in February of this year, arresting a suspect identified by the surname Gong in the northern city of Tianjin. Separately, US authorities had already apprehended an American suspect connected to the same network in the state of Georgia.
The ministry framed the outcome as evidence of deepening institutional ties between the two countries' law enforcement agencies, describing the case's resolution as a reflection of the "institutionalized operation" of China-US anti-drug cooperation and calling it "another practical outcome" of both sides' joint push against transnational crime.
The ministry added that the case underscores the "firm stance" of both nations' law enforcement bodies in "showing zero tolerance" toward drug-related offenses and cross-border criminal activity.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
